Add‐On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial
Journal of the American Heart Association · 15.09.2026 · 15 (18)
DOI: 10.1161/jaha.125.048729 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 15.09.2026. Verfasst von Yi-Ting Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine Taoyuan City Taiwan. Hauptthemen laut MEDLINE: Intracranial Arteriosclerosis, PCSK9 Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Antibodies, Monoclonal, Humanized. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Intracranial atherosclerotic stenosis is a major cause of ischemic stroke with high recurrence rates despite intensive therapy. The efficacy of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) as adjunctive treatment in intracranial atherosclerotic stenosis remains unclear.
Methods
We conducted a prospective, randomized, open‐label, blinded‐end point trial involving 62 patients with symptomatic intracranial atherosclerotic stenosis. Participants were randomized 1:2 to receive either a PCSK9i (alirocumab 75 mg every 2 weeks) plus high‐intensity statin or high‐intensity statin alone for 6 months. The primary outcome was the change in intracranial artery stenosis measured by high‐resolution vessel‐wall magnetic resonance imaging. Secondary outcomes included plaque enhancement volume, low‐density lipoprotein cholesterol target achievement (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine Taoyuan City Taiwan.
- Department of Diagnostic Radiology Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine Taoyuan City Taiwan.
- Department of Neurosurgery Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine Taoyuan City Taiwan.
- Department of Emergency Medicine Chang Gung Memorial Hospital at Chiayi, Chang-Gung University College of Medicine Taoyuan City Taiwan.
ORCID-Profile: Yi-Ting Pan, Yuan-Hsiung Tsai, Hsu-Huei Weng, Leng-Chieh Lin, Yen-Chu Huang
Zitieren
APA
Pan, Y. T., Tsai, Y. H., Weng, H. H., Lee, J. D., Yang, J. T., Lin, L. C., & Huang, Y. C. (2026). Add‐On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial. Journal of the American Heart Association, 15(18). https://doi.org/10.1161/jaha.125.048729
Vancouver
Pan YT, Tsai YH, Weng HH, Lee JD, Yang JT, Lin LC, et al. Add‐On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial. Journal of the American Heart Association. 2026;15(18). doi:10.1161/jaha.125.048729
BibTeX
@article{Pan2026,
author = {Pan, Yi-Ting and Tsai, Yuan-Hsiung and Weng, Hsu-Huei and Lee, Jiann-Der and Yang, Jen-Tsung and Lin, Leng-Chieh and Huang, Yen-Chu},
title = {Add‐On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {18},
doi = {10.1161/jaha.125.048729}
}
EUVIMED